Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Mar 24, 2022 9:54am
193 Views
Post# 34540990

"Dragging their FEAT", time to contact the Board of Director

"Dragging their FEAT", time to contact the Board of DirectorI'd drag my feat too, if the rewards were as plentiful as those paid to people we place in a position to honor the "FIDUCIARY DUTY" to shareholders.

I suggest Toray and Birch Hill get involved in the Fiduciary Process and rather quickly, given Spectral Medical is a TSX listed company, I find it near impossible to believe other TSX listed companies, like say BMO, would allow such corporate acitivity, this would include "accounting choices", other decisions around "disclosure" IR activity, including calls made directly to shareholders and such, but certainly it would run far beyond anything I have time to type.


I calculate 3 patients enrolled in the first ~ 25% of 2022 over what now reports on US trials.gov as 14 recruiting locations, many of which are very high profile hospitals here in the US...it gets better, so stay with me Donnie...

We reported the Colorado Springs location as recruting two patients in one month.  This leaves 1 patient enrolled over the balance of the 11-14 active sites for 2022....Hmmmmm??  I noted the comment from the "executive" stating that our 

340,000 safe uses over 27 years and FULL approval including an FDA approved diagnostic to guide in Canada since 2003 - 19 years...


Much more from me, seems we are "lacking posters aware of the production" ...

I always thought one day we would be on 60 Minutes, though an "acute thought", the angle far different than I had imagined,

"Getting their ACT together" ....OH indeed friend, the "ACT" is about as refined as that of the "actors" playing it out.
<< Previous
Bullboard Posts
Next >>